|
PSMC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.466800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.666000E-01 |
| Normal-vs-Stage2 |
7.458400E-01 |
| Normal-vs-Stage3 |
7.921600E-01 |
| Normal-vs-Stage4 |
2.689600E-02 |
| Stage1-vs-Stage2 |
2.027400E-01 |
| Stage1-vs-Stage3 |
3.124600E-01 |
| Stage1-vs-Stage4 |
6.684100E-02 |
| Stage2-vs-Stage3 |
5.431800E-01 |
| Stage2-vs-Stage4 |
2.481800E-02 |
| Stage3-vs-Stage4 |
2.225900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.633160E-01 |
| Normal-vs-AfricanAmerican |
2.677800E-01 |
| Normal-vs-Asian |
2.483600E-01 |
| Caucasian-vs-AfricanAmerican |
2.034000E-02 |
| Caucasian-vs-Asian |
8.585600E-01 |
| AfricanAmerican-vs-Asian |
3.661700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.435200E-01 |
| Normal-vs-Female |
3.819000E-01 |
| Male-vs-Female |
8.903800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.431600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.615600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.125200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.791600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.687200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.301600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.227200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.416200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.092600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.386200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.030500E-02 |
| Classical-VS-Follicular |
4.277200E-01 |
| Classical-VS-Other |
6.191400E-01 |
| Classical-VS-Normal |
2.953000E-01 |
| Tall-VS-Follicular |
7.648000E-02 |
| Tall-VS-Other |
6.733000E-01 |
| Tall-VS-Normal |
3.938500E-02 |
| Follicular-VS-Other |
5.406600E-01 |
| Follicular-VS-Normal |
8.675600E-01 |
| Other-VS-Normal |
4.057800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.013600E-01 |
| Normal-vs-N1 |
9.156500E-02 |
| N0-vs-N1 |
6.119600E-02 |
|
|
